NCT07719582

Brief Summary

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of this research study is to ascertain whether the integration of a proactive tongue strengthening exercise regimen, utilizing a Non-Significant Risk (NSR) Device, contributes to an observable improvement in speech fluency.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Jan 2028

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 1, 2028

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2029

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 18, 2026

Last Update Submit

July 18, 2026

Conditions

Keywords

Tongue-strengthening self-exercises (TSsE)Tongue strengthHome-based exerciseSelf-exercise

Outcome Measures

Primary Outcomes (2)

  • P1821

    The primary key performance indicator will be the proportion of study participants who demonstrate statistically significant and measurable improvements in their speaking ability following the completion of the two-week treatment protocol within P1821. This metric is crucial for evaluating the efficacy of the intervention and will be assessed through standardized linguistic and speech pathology evaluations.

    From enrollment to the end of treatment at 2 weeks.

  • P1821

    Compare the number of participants experiencing treatment-related adverse events versus those with positive treatment outcomes.

    From enrollment to the end of treatment at 2 weeks.

Study Arms (1)

P1821 #1

EXPERIMENTAL

P1821 interventions are administered once daily over a period of fourteen days.

Device: P1821

Interventions

P1821DEVICE

The P1821 intervention is distinguished by its independence from pharmaceutical agents and electronic devices. Its foundational mechanism is predicated exclusively on the physiological principles of muscle resistance training, thereby offering a non-pharmacological and non-invasive therapeutic approach.

P1821 #1

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Can read and write
  • Willing and able to follow the requirements of the protocol

You may not qualify if:

  • Previously seen and treated by speech and language pathologist for dysphagia or dysarthria for non-head and neck cancer causes
  • Medical instability, restlessness, or other factors that would compromise data acquisition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

N/A - Remote Study

Naples, Florida, 34119, United States

Location

Related Publications (8)

  • Binger C, Ragsdale J, Bustos A. Language Sampling for Preschoolers With Severe Speech Impairments. Am J Speech Lang Pathol. 2016 Nov 1;25(4):493-507. doi: 10.1044/2016_AJSLP-15-0100.

    PMID: 27552110BACKGROUND
  • Potter NL, Nievergelt Y, VanDam M. Tongue Strength in Children With and Without Speech Sound Disorders. Am J Speech Lang Pathol. 2019 May 27;28(2):612-622. doi: 10.1044/2018_AJSLP-18-0023. Epub 2019 Feb 28.

    PMID: 31136240BACKGROUND
  • Lalakea ML, Messner AH. Ankyloglossia: the adolescent and adult perspective. Otolaryngol Head Neck Surg. 2003 May;128(5):746-52. doi: 10.1016/S0194-59980300258-4.

    PMID: 12748571BACKGROUND
  • Wang J, Yang X, Hao S, Wang Y. The effect of ankyloglossia and tongue-tie division on speech articulation: A systematic review. Int J Paediatr Dent. 2022 Mar;32(2):144-156. doi: 10.1111/ipd.12802. Epub 2021 May 22.

    PMID: 33964037BACKGROUND
  • Belmehdi A, Harti KE, Wady WE. Ankyloglossia as an oral functional problem and its surgical management. Dent Med Probl. 2018 Apr-Jun;55(2):213-216. doi: 10.17219/dmp/85708.

    PMID: 30152627BACKGROUND
  • Wei EX, Tunkel D, Boss E, Walsh J. Ankyloglossia: Update on Trends in Diagnosis and Management in the United States, 2012-2016. Otolaryngol Head Neck Surg. 2020 Nov;163(5):1029-1031. doi: 10.1177/0194599820925415. Epub 2020 May 19.

    PMID: 32427523BACKGROUND
  • Suter VG, Bornstein MM. Ankyloglossia: facts and myths in diagnosis and treatment. J Periodontol. 2009 Aug;80(8):1204-19. doi: 10.1902/jop.2009.090086.

    PMID: 19656020BACKGROUND
  • Walsh J, Tunkel D. Diagnosis and Treatment of Ankyloglossia in Newborns and Infants: A Review. JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1032-1039. doi: 10.1001/jamaoto.2017.0948.

    PMID: 28715533BACKGROUND

Related Links

MeSH Terms

Conditions

Ankyloglossia

Condition Hierarchy (Ancestors)

Stomatognathic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All study participants will get the same intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2026

First Posted

July 22, 2026

Study Start (Estimated)

January 1, 2028

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

January 1, 2030

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations